Tear Film Innovations Completes $8.5 Million Series B Funding

by Business Wire • 2018/05/22 • 0 Comments

SAN DIEGO--(BUSINESS WIRE)--Tear Film Innovations completes $8.5 million Series B Preferred Stock funding round led by Visionary Ventures Fund, L.P. and Bluestem Capital.

Full Story →

← PanOptica Doses First Patient with New Formulation of PAN-90806, a Novel, Topical Anti-VEGF Eye Drop, in Phase 1/2 Clinical Trial

Aerpio Announces Initiation of Dosing in a Phase 1a, Multiple-Ascending Dose Study of AKB-4924, a Hypoxia-Inducible Factor-1 Alpha Stabilizer in Development for Inflammatory Bowel Disease →

Post navigation